drugset / Trial / NCT00328562

ZD1839 With Hypofractionated Radiation Therapy With an Immobilization Device for Advanced Non-Small Cell Lung Cancer

NCT00328562

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the safety and effectiveness of Iressa when used with a short course of high dose radiation therapy in patients with lung cancer.

Timeline

Start
2003-12
Primary completion
2008-04
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Gefitinib Small molecule